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We present a camera-based device capable of capturing two photoplethysmographic PPG signals
at two different wavelengths simultaneously, in a remote noncontact manner. The system comprises
a complementary metal-oxide semiconductor camera and dual wavelength array of light emitting
diodes 760 and 880 nm. By alternately illuminating a region of tissue with each wavelength of
light, and detecting the backscattered photons with the camera at a rate of 16 frames/wavelength s,
two multiplexed PPG wave forms are simultaneously captured. This process is the basis of pulse
oximetry, and we describe how, with the inclusion of a calibration procedure, this system could be
used as a noncontact pulse oximeter to measure arterial oxygen saturation SpO2 remotely. Results
from an experiment on ten subjects, exhibiting normal SpO2 readings, that demonstrate the
instrument’s ability to capture signals from a range of subjects under realistic lighting and
environmental conditions are presented. We compare the signals captured by the noncontact system
to a conventional PPG signal captured concurrently from a finger, and show by means of a J. Bland
and D. Altman Lancet 327, 307 1986; Statistician 32, 307 1983 test, the noncontact device to
be comparable to a contact device as a monitor of heart rate. We highlight some considerations that
should be made when using camera-based “integrative” sampling methods and demonstrate through
simulation, the suitability of the captured PPG signals for application of existing pulse oximetry
calibration procedures. © 2007 American Institute of Physics. DOI: 10.1063/1.2724789
I. INTRODUCTION
Pulse oximetry1–4 the noninvasive measuring of arterial
oxygen saturation has, since its invention by Aoyagi in
1973,5 become a crucial clinical tool for monitoring the
health of critically ill, anaesthetized, and recovering
patients.1 It is primarily employed as the earliest warning of
hypoxic hypoxia and has become a standard of care in oper-
ating and recovery rooms in many countries. A conventional
pulse oximeter sensor consists of two light emitting diodes
with different peak emission wavelengths, typically 660 nm
red and 940 nm infrared,6–8 and a photodiode detector,
housed in a probe that is attached around a patient’s finger.
The light emitting diodes LED are alternately energized
and the transmitted light passes through the tissue and is
detected by the photodiode in a multiplexed fashion. Since
red blood cells, or more specifically the oxygen carrying
molecule hemoglobin present on red blood cells, is the prin-
cipal absorber in tissue at these wavelengths, the received
light intensity at the photodiode is largely proportional to the
absorption by blood. The wavelengths of the LEDs are cho-
sen to have maximum absorption by deoxygenated hemoglo-
bin Hb at the red wavelength, and oxygenated hemoglobin
HbO2 at the infrared wavelength, thus the ratio of absorp-
tion at the two wavelengths is proportional to the concentra-
tions of Hb and HbO2, and hence oxygen saturation. Where
light from the LEDs has passed through an artery, the re-
ceived light intensity contains a photoplethysmogram PPG
at each wavelength, which is the modulation in absorptivity
caused by the peripheral arterial pressure wave form. The
PPG contains a dc offset due to absorption by venous blood,
other tissues, and scattering losses. Pulse oximeters extract
the PPG signal at each wavelength and by comparing the
logarithms of the ratios, of peaks and valleys, and of corre-
sponding pulses from each PPG, one produces a variable
called the ratio of ratios ROS according to2,3
ROS =
lnRL/RH
lnIRL/IRH
. 1
The subscripts L and H denote the valleys and peaks, respec-
tively, of the red R and infrared IR PPG signals. Since
ROS is obtained from the PPG signals only, it is proportional
to the variable of clinical interest, the arterial oxygen satura-
tion SpO2, which is defined as1
SpO2 =
HbO2
HbO2 + Hb
 100 % . 2
An empirically derived calibration table, specific to the pre-
cise two wavelengths used, maps the ROS variable to an SpO2
arterial oxygen saturation percentage.3
In addition, clinical pulse oximeters monitor and display
the patient’s heart rate, using the PPG wave form, and dis-
play a plethysmograph trace. The plethysmogram is used to
give a quick indication of the cardiac rhythm and any
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changes in its regularity.1 When the displayed trace is not
normalized, the plethysmogram will indicate sudden changes
in cardiac output or hypovolemia, which is an important
function of a clinical device that may otherwise continue
displaying valid SpO2 values, despite the diminishing PPG
amplitude.1 Where the plethysmogram is completely unproc-
essed the arterial wave form may be seen superimposed on
the slower respiratory wave form, though the amplitude of
this wave form varies with intrathoracic and central venous
pressure.9
Motivated by trends towards remote sensing in general,
the desire to reduce the physical restrictions and cabling as-
sociated with patient monitoring, removal of potentially in-
jurious wires from magnetic resonance imaging MRI
machines,10–12 and the possible new insights that might come
from haemodynamic imaging and mapping, researchers have
been working towards noncontact, remote camera-based
pulse oximetry. The feasibility of a remote camera-based ap-
proach has been well demonstrated. We have previously re-
ported the capture of PPG wave forms from extremities at
one wavelength in a transmission modality at 810 nm using a
complementary metal-oxide semiconductor CMOS
camera.
13 Wieringa et al. reported the reflection mode cap-
ture of “heartcycle-related” pulsatile variations also using a
CMOS camera.14 They employed illumination wavelengths
of 660, 810, and 940 nm; however, simultaneous capture was
not demonstrated. We have also previously reported the first
simultaneous capture of PPG signals at two wavelengths
760 and 880 nm in both transmission and reflection
modalities.15,16 However, the reflection mode PPG signals
were weak and unsuited to the application of Eq. 1 for the
derivation of conventional pulse oximeter calibration tables.
Instead we applied the modified Beer-Lambert law as a set of
simultaneous equations to estimate the concentrations of Hb
and HbO2. This method is common in studies of tissue oxy-
genation but is impractical for a clinical device, as it requires
the estimation of the optical path length and differential path
length factor for both wavelengths, for each subject and for
each observation location.17–19 In addition the system was
limited to small extremities typically fingers where arteries
are close to the surface.
In this article we present a system capable of capturing
two PPG signals at two different wavelengths simultaneously
and in a remote noncontact manner. We present results from
an experiment on ten subjects and show the system to be
capable of obtaining good quality PPG signals from deep
tissue, and evaluate the comparability of the device with a
conventional contact instrument.
II. METHODS
A. Instrumentation
The main components of the imaging system are de-
picted in Fig. 1. The camera a monochromatic Pixelink PL-
A741 uses a 2/3 in. CMOS sensor with 1280
1024 square pixels of length 6.7 m. Pixels are encoded
using 8 bits. The camera is connected to a personal comp-
upter PC via an IEEE 1394 connection. The camera is
manually focused on the tissue under investigation by a
C-mount zoom lens focal length of 18–108 mm,
f2.5—closed. A NIR bandpass glass filter is mounted di-
rectly in front of the lens. Upon receiving a trigger, the cam-
era exposes all pixels within a user specified region of inter-
est for the desired exposure time and then applies a global
shutter, such that all pixels are exposed for the same dura-
tion. Captured files are saved to the PC as a video file in
uncompressed AVI format. The camera is mounted on a tri-
pod with the lens face approximately 30 cm from the surface
of the tissue under investigation.
The light source is positioned perpendicular to the tissue
surface at a distance of approximately 15 cm. The source is
composed of 36 LED—18 with a peak wavelength of
760 nm and 18 with a peak wavelength of 880 nm.20 The
arrangement of the 760 and 880 nm LEDs is depicted in the
lower inset of Fig. 1. The diodes used are metal cased with
built-in glass lenses and have a half intensity beam angle of
30°. The 880 nm diodes Opto Diode Corp. OD880-L emit
17 mW at a forward current of 100 mA. The 760 nm diodes
Opto Diode Corp. custom wavelength L-package emit
10 mW at the same forward current. At 880 and 760 nm the
camera has spectral sensitivities of 0.055 and 0.091 A/W,
respectively. A control circuit alternately energizes each of
the wavelengths on the array, such that the array alternately
produces equal duration pulses of diffuse light centered at
760 and 880 nm. As either wavelength on the array is being
energized, the camera receives a trigger signal and begins
integration of a frame. The relative timing of the signal is
illustrated in the upper inset of Fig. 1. In order to identify the
peaks and troughs of the of the multiplexed PPG wave forms
as accurately as possible, it is desirable to use the highest
possible frame rate. The maximum achievable frame rate is
determined by the exposure time of a frame and the associ-
ated readout time, which is proportional to the frame size.
The minimum required exposure time is determined experi-
mentally as the shortest exposure time that results in suffi-
ciently well defined PPG signals. To eliminate any error due
FIG. 1. Illustration of noncontact dual wavelength PPG system, depicting
illumination and imaging geometry, relative timing of events upper inset,
and arrangement of LED array lower inset.
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to dropped frames an indicator fiber coupled to an 880 nm
LED provides a synchronization signal as part of the camera
image.
The illumination scheme used is depicted in Fig. 1. The
LED array is positioned to shine perpendicularly onto an
area of tissue to one side of the camera’s field of view. The
camera images a comparatively poorly illuminated area of
tissue adjacent to the brightly illuminated area. NIR light
from a point source will scatter throughout the surrounding
tissue; however, it has been shown theoretically and
experimentally21 that backscattered light detected on the tis-
sue surface is most likely to have traveled along a curved
“banana-shaped” path through the tissue, the depth of the
curve being proportional to the separation between the
source and detector. In addition to light incident from the
array and light reflected from the surface, the camera cap-
tures some light that has passed through the tissue. In some
regions of the camera’s field of view, backscattered light will
have passed through an artery and have been modulated by
the pulsing blood flow.
B. Signal acquisition and processing
Recorded videos are processed offline using MATLAB®.
By searching for the presence or absence of the indicator
light, videos are split into two sequences of frames; one il-
luminated at 760 nm and the other at 880 nm, each sequence
being half the original sampling rate. The process is illus-
trated in Fig. 2. Each frame is divided into boxes or groups
of adjacent pixels of dimensions 4040 pixels. The aver-
age value of the pixels in each box is tracked from frame to
frame as depicted in Fig. 2a. This process is performed for
both sequences of frames. Where backscattered light emerg-
ing from a box has passed through an artery, a PPG signal
can be detected in the time-varying mean value of that box as
in Fig. 2b. This process yields two multiplexed PPG sig-
nals, captured at two wavelengths simultaneously—the pre-
requisite for pulse oximetry.
C. Experimental protocol
Experiments were conducted using ten healthy subjects
10 Caucasian, 9 male, and 1 female aged between 21 and
45 years mean 31.70 years and standard deviation
6.37 years. Subjects were seated in an upright position with
their right arms resting, volar side upwards, on a cushioned
bench. A conventional reflection mode contact PPG sensor
BioPac UIM100C was connected to the subjects’ right in-
dex fingers, and a conventional transmission mode contact
pulse oximeter sensor Nellcor probe/Welch Allyn pulse
oximeter to their left index fingers. The camera was posi-
tioned and focused such that an area of the volar side of the
forearm close to the wrist was in view and occupying most
of the image. The LED array was positioned so as to illumi-
nate an area on the proximal side of the imaged area as
illustrated in Fig. 3a. Overhead fluorescent lighting was
present during the experiments main supply 50 Hz. Once
stable pulse rate and SpO2 readings were indicated by the
pulse oximeter, a trigger signal was sent simultaneously to
the camera system and the PPG data acquisition system, ini-
tiating a 20 s capture of data by both devices. The camera
was configured to capture 640 frames, at a resolution of
640480 pixels, with a 20 ms exposure time. The camera
was triggered externally at a rate of 32 frames/s and the
illumination array correspondingly switched LED wave-
lengths at 16 Hz. The LED array was activated prior to each
experiment to allow the diodes reach their stable operating
temperature and wavelengths.22 The subjects were asked to
sit motionless and to breathe normally during the experi-
ments.
III. TESTING AND PERFORMANCE
To successfully replace a conventional device in any ap-
plication, a noncontact pulse oximeter should perform com-
parably the three main functions of a pulse oximeter, namely,
measure SpO2, measure heart rate, and display a
plethysmogram.1 For clinical purposes the word “compara-
bly” means that measurements by the two instruments should
FIG. 2. Signal acquisition and image processing.
FIG. 3. Illustration of illumination and imaging positions A and sample
frame from the 880 nm sequence B. The white box encloses an area of
4040 pixels—the time varying mean value of which is plotted in Fig. 4.
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agree sufficiently closely that actions and decisions regarding
the patient would not change depending on the instrument
used. We present an analysis of the comparability of the con-
tact and noncontact devices, with respect to the three primary
functions of a clinical pulse oximeter, using graphical and
numerical techniques as appropriate.
A. Display a plethysmogram
The results of a typical experiment are presented here.
Figure 3a illustrates the relative position of the imaged and
illuminated areas of tissue. Figure 3b displays a sample
frame from the 880 nm frame sequence. Imposed on the
sample frame is a white square of dimensions 40
40 pixels. Also visible in the top right corner of Fig. 3b
is the edge of the indicator fiber. The mean values of the
pixels contained in the white square are plotted against time
in Fig. 4. Note that the camera derived wave forms have
been inverted so that their vertical axes correspond to light
absorption rather than received light intensity; light absorp-
tion being directly proportional to the peripheral arterial
pressure wave form; the received light intensity being in-
versely proportional. The systolic peaks and diastolic
troughs, along with the dichrotic notch the inflection in the
wave form associated with a momentary backflow of blood
caused by the abrupt closure of the aortic valve, are clearly
visible. The Fourier spectra of the three PPG signals in Fig. 4
are plotted in Fig. 5. The pulsatile component is clearly vis-
ible in all three spectra at 1.5 Hz. The component due to
respiration is clear in both noncontact signals at 0.35 Hz,
though is less pronounced in the contact PPG spectrum from
this subject. The low-frequency vasomotion and Mayer wave
oscillations are present in all three spectra as distinct peaks
between 0 and 0.1 Hz.
B. Measure heart rate
Here we assess the agreement between the contact and
noncontact measurements of heart rate using the Bland-
Altman method.23,24 This is a popular method of assessing
agreement between two clinical devices, where both devices
exhibit a certain amount of measurement error. It is preferred
to alternative methods, most notably the use of the correla-
tion coefficient, as it identifies bias between the devices. To
obtain a heart rate measurement for each subject over the
20 s observation window, the Fourier spectra of the contact,
760 and 880 nm PPG signals were calculated and the peak
frequency of the cardiac component noted. Figure 6 shows a
scatter plot of the heart rate measurement from the contact
device versus the measurement from the noncontact device.
The noncontact 760 nm measurements are plotted as circles
and the 880 nm measurements as crosses. Where the circles
and crosses align the noncontact measurements agree at both
wavelengths, for that subject. Also plotted in Fig. 6 is the
line x=y, where data points lie along this line there is perfect
agreement between the two devices, while deviation from the
line indicates disagreement. It is worth noting there will be
perfect correlation between the devices if the points lie along
any straight line. It can be seen in Fig. 6 that for each sub-
ject the noncontact device indicates exactly the same mea-
surement of heart rate at 760 and 880 nm. For eight subjects,
both the contact and noncontact devices are in perfect agree-
ment; however, for two subjects the noncontact device re-
corded a slightly lower heart rate than the contact device.
Since the two devices are in agreement for higher, interme-
diate, and lower heart rates, and since both devices agree for
other heart rate measurements in this range, we can conclude
FIG. 4. Comparison of noncontact PPG signals and conventional PPG
signal.
FIG. 5. Comparison of Fourier spectra of noncontact and conventional PPG
signals.
FIG. 6. Scatter plot showing noncontact device’s measurement of heart rate
at 760 nm circles and 880 nm crosses, vs the contact device’s measure-
ment, for each subject. Also shown is the line x=y, where both devices are
in perfect agreement about the measurement.
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that the disagreement for these two subjects is not systemic
to either device.
Figure 7 shows a Bland-Altman plot of the mean of the
measurements by both devices for each subject versus the
difference between the measurements by both devices for
each subject. Again data pertaining to 760 nm are repre-
sented by circles and 880 nm by crosses. If the two devices
disagreed more, this plot would allow us to identify any re-
lationship between the measurement error and the true value
of the variable of interest of which, the mean of the two
measurements is the best estimate we have. For these sub-
jects the mean difference between the measurements by each
device is −0.0150 Hz and the standard deviation SD is
0.0337 Hz. Assuming that the mean difference between the
devices is normally distributed, the 95% confidence interval
can be calculated at ±1.96 SD though it would take many
more samples of the measurement difference between the
devices to establish if the difference is normally distributed,
and a histogram would show that these samples are not. In
this case the ±1.96 SD range means that the noncontact de-
vice may indicate a heart rate of 4.8687 beats/min below or
3.0687 beats/min. above the contact device, which is suffi-
ciently close for the two devices to be used interchangeably.
C. Measure SpO2 „ratio of ratios…
Pulse oximeters calculate SpO2 by way of an interim
variable ROS and then employ empirically derived calibration
curves to convert ROS to SpO2. In addressing the suitability of
noncontact PPG signals for use with existing methods of
determining ROS such as the peak and valley method or the
derivative method3 two points about camera-based systems
should be noted that have not yet been reported in studies on
the feasibility of such systems. The first is the effect of low
frame rates. Pulse oximeters typically sample at 480 Hz,
sampling each wavelength and a dark sample in succession.7
Camera-based systems will never enjoy these frame rates;
however, at very low rates as low as 6.7 frames/s have been
reported the error in estimating the amplitude of the PPG
peaks and valleys that can result from sampling the wave
form before or after the actual inflection are significant. Sec-
ond, this problem is compounded by the way a camera col-
lects its data. The photodiode in a contact device produces a
continuously varying output current that is converted to a
voltage and sampled by a sample-and-hold circuit once every
2 ms. The camera exposes its CMOS or charge-coupled de-
vice CCD chip for typically tens of milliseconds and then
has a short readout time before beginning the next exposure.
However, the value readout at the end of the exposure is not
an instantaneously sampled value but rather a charge propor-
tional to the sum of all photons received during the
exposure—that is, the camera derived signal is proportional
to the mean value observed during exposure. This integration
effect means the camera produces an underestimation when
the wave form has a positive slope and an overestimation
when the wave form has a negative slope. Thus the camera-
derived wave form appears to lag the sample-and-hold wave
form and has reduced peak-to-valley amplitude.
To quantify the effect of this phenomenon on the calcu-
lation of ROS, we simulated the camera integration effect at
16 frames/wavelength s on a synthetic PPG wave form
constructed by summing three sinusoids at typical cardiac,
respiratory, and vasomotion frequencies and investigated the
variation in ROS values between the sample-and-hold and
integrated wave forms, for varying oxygen saturation levels
and heart rates. Changes in oxygen saturation levels were
emulated by altering the IR:red PPG amplitudes between ap-
proximately 2.3 and 0.5, which for wavelengths of 660 and
940 nm would correspond to SpO2 levels between approxi-
mately 100% and 60%.1,2 ROS was calculated using Eq. 1.
The results are summarized in Table I. The discrepancy be-
tween ROS calculated from the sample-and-hold wave form
and from the integrated wave form varies with both heart rate
and oxygen saturation. The difference is largest when the
heart rate and oxygen saturation are at their highest. At lower
heart rates the simulated PPG has smaller slopes and the
integration effect is less pronounced. Similarly as the ratio of
the infrared and red PPG amplitudes varies with oxygen
saturation, the quotient of the integration error for each
wavelength also varies—canceling itself out when the PPG
wave forms have similar amplitudes. Within the range of
heart rate and oxygen saturation values simulated, compared
to the contact technique, the noncontact technique produced
a maximum overestimation of ROS of 2.6% and maximum
FIG. 7. Bland-Altman mean vs difference plot, showing the average of the
heart rate measurements by the contact and noncontact devices, vs the dif-
ference between their measurements, for each subject. The circles indicate
measurement at 760 nm, and the crosses at 880 nm. Also plotted are lines
indicating the mean of the differences and ±1.96 standard deviations about
the mean.
TABLE I. Simulated percentage error in measurement of ROS by integrative
sampling camera based compared to sample-and-hold contact method.
Results pertain to a synthetic contact signal sampled at 160 Hz sample-and-
hold method and the camera derived version of that signal at 16 frames/s.
Approx.
SpO2
%
IR:R PPG
scaling factor
Pulse rate
50 72 100
100 2.32 1.3 1.69 2.58
1.66 0.69 0.9 1.35
85 1 0 0 0
0.81 −0.2 −0.28 −0.4
60 0.47 −0.51 −0.73 −1.09
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underestimation of −1.1%. The SpO2 measurement error as-
sociated with a conventional pulse oximeter is approximately
±3%.3,25 If the ROS differences summarized in Table I were
translated directly in the SpO2 measurement differences, the
noncontact device might not be comparable with a conven-
tional device at high levels of oxygen saturation and particu-
larly for high heart rates. At lower levels of oxygen satura-
tion the differences between devices are less than the ±3%
measurement error associated with conventional pulse
oximetry.
IV. DISCUSSION
Though obstacles to developing a clinically useful de-
vice remain, the allure of a noncontact pulse oximeter and
the ability to measure SpO2 and heart rate and observe a PPG
by noncontact means are strong. Such an instrument will not
compete with conventional devices for routine bedside moni-
toring or for ambulatory monitoring, but would most likely
find application in specialized areas such as sleep studies,
intensive care, or in conjunction with other modalities such
as MRI.
The instrument presented here performs comparably
with a conventional contact device as a measure of heart rate
and as a capturing system for the PPG wave form. We have
drawn attention to the effect of an integrative sampling tech-
nique inherent to all camera-based approaches as compared
to a conventional sample-and-hold method. While this is
something to consider when converting ROS values to SpO2
values, the simulation results indicate that interdevice differ-
ences may be clinically significant only at very high oxygen
saturations—though the necessity to ascertain precise SpO2
measurements in this region is less critical than at lower
saturations, where a patient may be in danger.1 The ultimate
solution to this is higher frame rates though it may also be
possible to account for integrative effects during the calibra-
tion procedure or by applying time-domain system identifi-
cation techniques to the captured PPG signals. We contend,
however, that the recorded PPG signals are suitable for the
application of existing pulse oximetry calibration procedures
to convert PPG data to SpO2 values, which would yield full
pulse oximeter functionality through noncontact means.
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